In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.
Two T2-independent J-difference lactate editing schemes for the PRESS magnetic resonance spectroscopy localization sequence are introduced. The techniques, which allow for simultaneous acquisition of the lactate doublet (1.3 ppm) and edited singlets upfield of and including choline (3.2 ppm), exploit the dependence of the in-phase intensity of the methyl doublet upon the time interval separating two inversion (BASING) pulses applied to its coupling partner after initial excitation. Editing method 1, which allows for echo times TE = n/J (n = 1, 2, 3, . . . . ), alters the BASING carrier frequency for each of two cycles so that, for one cycle, the quartet is inverted, whereas, for the other cycle, the quartet is unaffected. Method 2, which also provides water suppression, allows for editing for TE > 1/J by alternating, between cycles, the time interval separating the inversion pulses. Experimental results were obtained at 1.5 T using a Shinnar Le-Roux-designed maximum phase inversion pulse with a filter transition bandwidth of 55 Hz. Spectra were acquired from phantoms and in vivo from the human brain and neck. In a neck muscle study, the lipid suppression factor, achieved partly through the use of a novel phase regularization algorithm, was measured to be over 10(3). Spectra acquired from a primary brain and a metastatic neck tumor demonstrated the presence of lactate and choline signals consistent with abnormal spectral patterns. The advantages and limitations of the methods are analyzed theoretically and experimentally, and significance of the results is discussed.
Department of Radiology, MC5488, Stanford University, Stanford, California, 94305, USA.
J
J
Star-Lack
D
D
Spielman
E
E
Adalsteinsson
J
J
Kurhanewicz
D J
DJ
Terris
D B
DB
Vigneron
D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000032:analysis; D001923:Brain Chemistry; D001932:Brain Neoplasms / Q000737:chemistry*; D002794:Choline / Q000032:analysis; D003401:Creatine / Q000032:analysis*; D005260:Female; D006801:Humans; D019344:Lactic Acid / Q000032:analysis*; D008055:Lipids / Q000032:analysis*; D008207:Lymphatic Metastasis; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008875:Middle Aged; D009333:Neck; D009334:Neck Muscles / Q000737:chemistry*; D019047:Phantoms, Imaging
D008055:Lipids; D001224:Aspartic Acid; D019344:Lactic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline